Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
For a list of compatible devices and operating system versions, please click here.
- You will receive an email invitation, “Request to view glucose data”, to join an Eversense® CGM user’s Circle.
Note: If you are expecting an invitation and do not see it in your Inbox, check your Spam or Junk folders.
- Click the link in the email.
- Log in to your Eversense account. If you do not have an account already, you will be able to create one.
Note: do not use the emailed link with a different email. The email address used for the account must match the one that received the link.
The Eversense® CGM user may also remove you from their Circle. If this happens, a notification will appear informing you that you have been removed from that person’s Circle when you next tap to view that person’s values.
The Eversense® E3 Transmitter is covered by a 1 year warranty.
The Eversense E3 CGM System uses a calibration algorithm that continuously assesses the sensor’s glucose sensitivity and based on this information, the system determines whether 1 or 2 calibrations/day are needed after day 21. This ensures the best possible system accuracy is maintained.
The Eversense E3 CGM System uses a calibration algorithm that continuously assesses changes in the sensor’s glucose sensitivity. This sensitivity varies by individual, and from day to day. The need for 1 or 2 calibrations/day is determined by the system based on this continuous assessment, and there is no specific action a user can take to change the frequency of calibrations. However, providing the system with an accurate blood glucose value is important. Always calibrate the system using only a fingerstick blood sample. DO NOT calibrate at times when glucose may be rapidly changing (e.g., after meals, after dosing insulin). DO NOT use an alternative site (such as forearm or palm) blood glucose reading to calibrate the system.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060